Read more about Lupin gains on launching penicillamine tablets on Business Standard. Lupin rose 3.18% to Rs 1055.05 after the company announced the launch of penicillamine tablets USP, 250 mg, having received an approval from the United States Food and Drug Administration (US FDA) earlier.